(–)-Maximiscin (1, Figure 1A) is a
unique 4-hydroxy-2-pyridone alkaloid, a class of natural products historically
represented by fascinating structural components and intriguing biological
activities. Recently, 1 has been shown to induce DNA damage, activate
DNA damage response pathways, and induce selective cytotoxicity against triple
negative breast cancer (TNBC). The Baran group has reported the first total
synthesis of 1 in a longest linear sequence of 10 steps. Their strategic
bond disconnections are shown in Figure 1B.
The synthesis is summarized in Scheme 1,
and showcases a C–H methoxylation step that acts to desymmetrize the pseudosymmetric
α-carbon of compound 10 (note that 8 is achiral and directing
group 9 is enantiopure) to afford 11. Notably, this is the most
complicated example of this methodology, however there is a caveat to note, and
it’s generally the “Achille’s Heel” of modern C–H activation methods, and that
is the subsequent removal of the directing group (i.e., aqueous HBr, 100 C, 15
h). Not many substrates will survive conditions like this; however, many
substrates used in medicinal chemistry (aromatic and heteroaromatic rings) are
quite stable and thus these methods can be employed in the design of druglike
molecules.
Other key transformations include an Ag/Fe
co-catalyzed stereoinvertive decarboxylative Giese addition, followed by 1,5
hydrogen atom transfer (HAT) and radical oxidation (i.e., 12 to 14,
Scheme 1), and an “Aza-Sakurai” cascade to construct the atropisomeric pyridone
ring in the penultimate step (i.e., 5 + 6 to 18, Scheme 1). Given the
creativity of the synthetic design, its biological relevance, and its first
total synthesis, this manuscript can be considered suitable for publication in
JACS.
Comments
Post a Comment